We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Aptamer Group Progresses Partnership With Unilever PLC

Scientist with an assay plate.
Credit: iStock.
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces the successful progression of its long-standing development partnership with Unilever for identification of Optimers capable of supporting the development of novel fast moving consumer goods (“FMCG”) applications.

Following formation of a partnership with Unilever in FY2023, Aptamer has successfully developed the required Optimers and demonstrated their performance through in-house assays. After being shipped to Unilever, the Optimers delivered highly positive and reproducible results in their laboratories, indicating their potential for use in downstream products. In parallel, Aptamer has streamlined the Optimers to improve their function and manufacturability and is working to transfer these to Unilever for further evaluation.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

Based on the successful progress of this scientific work, Aptamer and Unilever are now drafting patent applications to protect these developments and downstream commercial applications.

“We are delighted to support our partners at Unilever with Optimer technology that is providing novel solutions in multiple areas, now including fast-moving consumer goods. Over the past two years, we have worked closely with the team at Unilever, to develop successful binders and are pleased to see the promising results the binders are delivering in their laboratories, further validating our technology and leadership position in the affinity ligand market. With such strong results and the continued progression of this partnership, we are pleased to begin patenting these binders and allow the next stage of advances. I look forward to updating you on this project as it develops.”

Steve Hull, Chairman of Aptamer Group